Name: Retinal Imaging Devices Market News
Creator: Coherent Market Insights
License: https://www.coherentmarketinsights.com/privacy-policy
Keywords: Retinal Imaging Devices Market, Retinal Imaging Devices Market Report, Retinal Imaging Devices Industry Report, Retinal Imaging Devices Market Size, Retinal Imaging Devices Market Share, Retinal Imaging Devices Market Analysis, Retinal Imaging Devices Market Growth, Retinal Imaging Devices Market Trends, Retinal Imaging Devices Market Overview, Retinal Imaging Devices Market Forecast

Market News

Recent Developments

New product launches

On June 22, 2023, Eyenuk, a global artificial intelligence (AI) digital health company, and the leader in real-world applications for AI Eye Screening and AI Predictive Biomarkers, announced that the company had received U.S. Food and Drug Administration (FDA) clearance to use the Topcon NW400 retinal camera with its EyeArt AI system to automatically detect diabetic retinopathy (DR), adding to the already-cleared usage with Canon CR-2 AF and Canon CR-2 Plus AF cameras.
On March 13, 2023, Sony Electronics, a subsidiary of Sony Corporation, announced the DSC-HX99RNV kit, a new retinal projection camera kit that helps people with visual impairments see and capture the world around them. This kit consists of Sony's DSC-HX99 compact camera and QD Laser's RETISSA NEOVIEWERi , a viewfinder that uses laser retinal projection technology.
In April 2022, Optos Plc, a provider of high-resolution ultra-widefield (UWF) retinal imaging and image-guided Optical Coherence Tomography (OCT) devices for eye care professionals, announced the launch of the first CE-marked AI-based solution to automate the detection of more-than-mild diabetic retinopathy (DR) and diabetic macular odema, both vision-threatening diseases, using optomap ultra-widefield retinal images.
In June 2020, Vasoptic Medical, a medical device company, announced that it had received U.S. FDA 510 (k) clearance for the XyCAM RI noninvasive retinal imager. The XyCAM RI provides dynamic and quantifiable blood flow measurement synchronized with finger pulse oximeter data. The device images retinal vessels and blood flow with high spatio-temporal resolution, high reproducibility of measurements, and dynamic flow-sensitivity over a wide range, according to Vasoptic. The device provides multiple display modes for different applications, including reconstructed fundus image mode, dye-free angiogram mode, and colored flow visualization mode.

Acquisition and partnerships

On July 25 2023, RetinAI Medical AG, a leader in clinical and imaging data management software and advanced analytics using artificial intelligence (AI), and Retina Consultants of America (RCA), the largest retina care provider in the U.S. with more than 1.7million annual patient visits and over 200 locations in the U.S , announced a strategic partnership to develop the most extensive and AI-insight driven Real World Evidence (RWE) U.S.-based database in Ophthalmology.
On May 31, 2023, AINNOVATECH, a developer of artificial intelligence (AI)-powered healthcare solutions, chose ITEK, a growing medical device manufacturer, as their service provider for the development of a new retinal camera. This collaboration highlights AINNOVATECH’s commitment to revolutionizing the way retinal images are taken and providing accessible solutions to detect early-stage diseases.
On May 9, 2023, Optomed and Thirona Retina, a company specializing in the field of artificial intelligence (AI) assisted retinal image analysis, entered into a partnership to distribute Optomed Aurora handheld fundus camera together with Thirona Retina’s AI in Europe and selected Middle East and Asian countries.